The Glioblastoma Multiforme Treatment Market size was valued at USD 2.69 billion in 2023 and is expected to reach at USD 5.68 billion by 2031 and grow at a CAGR of 9.8% over the forecast period of 2024-2031.The landscape of Glioblastoma Multiforme (GBM) treatment market is both challenging and promising, characterized by relentless research pursuits and the quest for innovative therapies....
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian